New Jersey-based executive John Klein serves as the chairman of Cambridge Therapeutics. In addition to overseeing operations at Cambridge Therapeutics, John Klein takes an active interest in developments concerning health care and health policy.
New Jersey officials announced new rules intended to expand access to the state’s medical marijuana program, following the directive set in an executive order by Governor Phil Murphy. In addition to removing bureaucratic hurdles for young patients, the new policies will allow patients with a wider variety of diseases and ailments to access medical marijuana.
Taking effect May 20, 2019, the reforms also relax some of the regulations governing businesses that grow, produce, and sell medicinal cannabis. Other policies already in effect but now codified include reducing medical cannabis costs for patients and permitting doctors to prescribe medical marijuana without being named publicly as a physician participating in the program.